Sep 28, 2026 08:40AM
Sep 2, 2026 09:29AM
May 11, 2026 08:30AM
Apr 2, 2026 07:28AM
Feb 5, 2026 10:08AM
Jan 13, 2026 01:58PM
Jan 12, 2026 10:00AM NVIDIA and Lilly launch $1 billion AI lab for drug discovery
Jan 12, 2026 10:00AM
Jan 12, 2026 06:07AM
Jan 8, 2026 11:18AM
Dec 16, 2025 10:00AM
Nov 18, 2025 08:49AM
Aug 19, 2025 08:21AM
Aug 11, 2025 06:00PM Buy this U.S. large-cap biopharma stock: JPMorgan
Aug 8, 2025 09:43AM
Aug 7, 2025 02:00AM
Jul 7, 2025 09:44AM
May 27, 2025 10:00AM
May 27, 2025 10:00AM
May 24, 2025 10:00PM
Feb 26, 2025 10:00AM JPMorgan Reiterates Overweight Rating on Eli Lilly (LLY)
Jan 14, 2025 09:01AM
Jan 14, 2025 09:00AM
Jan 13, 2025 01:30PM
Jan 13, 2025 01:20PM
Jan 7, 2025 10:00AM
Nov 19, 2024 11:00AM
Nov 5, 2024 06:16AM Stocks to watch as White House race enters final stretch
Oct 30, 2024 06:53AM
Sep 17, 2024 02:00PM
Jul 11, 2024 06:53AM
Jul 3, 2024 07:43AM
May 24, 2024 11:04AM
Mar 8, 2024 11:04AM
Feb 5, 2024 11:47AM Midday movers: Estee Lauder, Eli Lilly and more
Jan 31, 2024 07:08AM
Jan 11, 2024 06:29AM
Jan 2, 2024 10:00AM
Dec 12, 2023 11:43AM
Nov 17, 2023 08:03AM
Oct 30, 2023 07:05AM
Aug 14, 2023 09:09AM Lilly Completes Acquisition of Versanis Bio
Jul 14, 2023 08:00AM
Jul 14, 2023 08:00AM
Apr 24, 2023 06:45AM
Apr 24, 2023 06:45AM
Apr 24, 2023 06:45AM
Mar 21, 2023 05:40AM
Mar 9, 2023 01:01PM J.P. Morgan sees recent Eli Lilly (LLY) weakness as opportunity ahead of Donanemab Ph3 Data
Jan 4, 2023 10:00AM

301,317 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All